Device / Technology News

RSS

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, embolization particles will show the most significant growth, both in procedure volume and in revenue, among all devices in the transcatheter embolization and occlusion (TEO) market. Radioembolization is expected to grow from $50 million in sales in 2011 to $128 million in 2015, while drug-eluting beads will grow from $11 million to $28 million over the same period.

21 Apr 2011

University of Freiburg launches new science portal, Surprising Science

The University of Freiburg is extending its communicative bounds with a brand new science portal, Surprising Science. Starting today, the university will regularly present exciting new research findings at www.surprising-science.de, some of them in multimedia form. The site will also provide comprehensive background information and news from daily life at the university.

21 Apr 2011

First UCLA patient with hand transplant doing well at six-and-a-half weeks

Six-and-a-half weeks after receiving the first hand transplant in the western United States, Emily Fennell is becoming so accustomed to her new right hand that she barely remembers when she didn't have one.

21 Apr 2011

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a contract to supply a Gamma Knife® Perfexion™ system to Lovelace Medical Center in Albuquerque, New Mexico.

21 Apr 2011

First implantation of blended vitamin E total knee replacement in the U.S

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the implantation of the first blended vitamin E total knee replacement in the U.S.

21 Apr 2011

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Women who choose among different breast cancer treatment options make smarter choices when getting the information and making decisions in small doses rather than all at once, as is customary, a University of Michigan study found.

21 Apr 2011

Astra Tech OsseoSpeed TX Profile implants now include Atlantis Abutments

Astra Tech expands their patient-specific abutment solution for North American customers, to now include Atlantis™ Abutments for Astra Tech OsseoSpeed™ TX Profile implants.

21 Apr 2011

US-LACRN selects Agilent gene expression microarrays for major breast cancer study

Agilent Technologies Inc. today announced that the United States-Latin American Cancer Research Network has selected Agilent Gene Expression microarrays and associated instruments for a major study of breast cancer in five Latin American nations.

21 Apr 2011

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

Biomagnetics Diagnostics Corp., (PINK SHEETS: BMGP) a developer of revolutionary diagnostic systems and related technology for detecting HIV, hepatitis, tuberculosis, cholera and malaria, and other innovative technologies, today announced it has now completed a series of payments to Los Alamos National Laboratory (LANL) pursuant to the cooperative research and development agreement (CRADA) executed in 2010 between the two organizations.

21 Apr 2011

ICA selected by Central Illinois HIE as vendor of choice

Informatics Corporation of America announced today that it has been selected by the Central Illinois Health Information Exchange (CIHIE), www.qualityquest.org, as its health information exchange vendor of choice and has begun contract negotiations to furnish the technology and infrastructure for a regional HIE that will serve 20 counties in the Peoria, Bloomington, Champaign, and Decatur areas of Illinois.

21 Apr 2011

Breath test shows promise for detection of head-and-neck cancers

Scientists reveal that an 'electronic nose' can distinguish between molecules found in the breath of head-and-neck cancer patients and those of healthy people, according to the results of a small, initial study published in the British Journal of Cancer, today.

21 Apr 2011

BSD Medical sells hyperthermia systems to a U.S. Government medical facility

BSD Medical Corporation (NASDAQ:BSDM) (the "Company" or "BSD") announced today that a U.S. Government medical facility has purchased a BSD-500 Hyperthermia System (BSD-500).

21 Apr 2011

RTCA HT instrument from Roche employs high-throughput real-time cell analysis

The new xCELLigence RTCA HT Instrument from Roche (SWX:RO) (SWX:ROG) (Pink Sheets:RHHBY) rounds out the Diagnostics Applied Science's portfolio in real-time cell analysis with a high-throughput product.

21 Apr 2011

Immigrant screening fails to detect more than 70% cases of latent tuberculosis infection

Current UK procedures to screen new immigrants for tuberculosis (TB) fail to detect more than 70 per cent of cases of latent infection, according to a new study published in The Lancet Infectious Diseases.

21 Apr 2011

FDA approves St. Jude Medical's Trifecta valve for stented aortic valve replacement

St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.

21 Apr 2011

Intrinsic Bioprobes launches mass spectrometry-based protein assays for in-vitro diagnostic testing

Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing. The assays for beta-2-microglobulin, cystatin C, and retinol binding protein are performed on IBI's MASSAY® platform at the CLIA-certified and College of American Pathology (CAP) accredited diagnostic laboratory of the Institute of Genomics Medicine, UMDNJ-New Jersey Medical School.

20 Apr 2011

InfraReDx's LipiScan IVUS Coronary Imaging System receives European CE Mark approval

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced it has received CE Mark approval to begin commercialization of the LipiScan™ IVUS Coronary Imaging System throughout Europe.

20 Apr 2011

Roche's cobas HPV Test receives FDA approval for cervical cancer screening

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent many women from developing this deadly disease.

From Roche Sequencing and Life Science 20 Apr 2011

Spacelabs Healthcare introduces XPREZZON patient monitoring solution

Spacelabs Healthcare, which decades ago pioneered medical telemetry to monitor the vital signs of orbiting astronauts, today announced the launch of XPREZZON, a patient monitoring solution that delivers innovative technology and design to shape the new age of care for clinicians and patients alike.

20 Apr 2011

Florida Hospital uses flexible surgery instruments from Apollo Endosurgery for stomach tumor extraction

Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain.

20 Apr 2011

Device / Technology News

MRG: Radioembolization is expected to grow from $50M in sales in 2011 to $128M in 2015

University of Freiburg launches new science portal, Surprising Science

First UCLA patient with hand transplant doing well at six-and-a-half weeks

Lovelace Medical Center upgrades to Gamma Knife Perfexion system

First implantation of blended vitamin E total knee replacement in the U.S

Providing complete information about breast cancer treatment options often ends up overwhelming patients

Astra Tech OsseoSpeed TX Profile implants now include Atlantis Abutments

US-LACRN selects Agilent gene expression microarrays for major breast cancer study

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

ICA selected by Central Illinois HIE as vendor of choice

Breath test shows promise for detection of head-and-neck cancers

BSD Medical sells hyperthermia systems to a U.S. Government medical facility

RTCA HT instrument from Roche employs high-throughput real-time cell analysis

Immigrant screening fails to detect more than 70% cases of latent tuberculosis infection

FDA approves St. Jude Medical's Trifecta valve for stented aortic valve replacement

Intrinsic Bioprobes launches mass spectrometry-based protein assays for in-vitro diagnostic testing

InfraReDx's LipiScan IVUS Coronary Imaging System receives European CE Mark approval

Roche's cobas HPV Test receives FDA approval for cervical cancer screening

Spacelabs Healthcare introduces XPREZZON patient monitoring solution

Florida Hospital uses flexible surgery instruments from Apollo Endosurgery for stomach tumor extraction

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News